External quality assessment of Syva Emit and Abbott TDx II assays for methotrexate in serum

Therapeutic Drug Monitoring

Volumn 18, Issue 6, 1996, Pages 721-723

  Wilson, John F ^a   Tsanaclis, Lolita M ^b   Barnett, Kathleen ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b Cardiff Bioanalytical Services Ltd   (United Kingdom)

Author keywords

Accuracy; Outliers; Precision; Proficiency testing; Sensitivity

Indexed keywords

METHOTREXATE;

ACCURACY; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MONITORING; HUMAN; IMMUNOASSAY; PRIORITY JOURNAL; QUALITY CONTROL;

ANTIMETABOLITES, ANTINEOPLASTIC; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; EUROPE; HUMANS; LABORATORIES; METHOTREXATE; QUALITY CONTROL; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS;

EID: 0029804616     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199612000-00016     Document Type: Article

References (2)

1. Evans WE, Pratt CB, Taylor RH, Barker LF, Crom WR. Pharmacokinetic monitoring of high-dose methotrexate: early recognition of high-risk patients. Cancer Chemother Pharmacol 1979;3: 161-6.
2. Healy MJR. Outliers in clinical chemistry quality-control schemes. Clin Chem 1979;25:675-7.